1317P Real-world immunotherapy (IO) rechallenge outcomes with nivolumab (NIV) in advanced non-small cell lung cancer (aNSCLC) in France: LIST study interim results
| Autor: | Godbert, B., Gobbini, E., Zysman, M., Decroisette, C., Lena, H., Moro-Sibilot, D., Guisier, F., Egenod, T., Couraud, S., Brellier, F., Fleuriet, A., Khalife, Y., Girard, N. |
|---|---|
| Zdroj: | In Annals of Oncology September 2024 35 Supplement 2:S838-S839 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|